| P50 | author | Johannes Hebebrand | Q30000133 |
| | Frank Geller | Q56839812 |
| P2093 | author name string | Pierre A Beitinger | |
| | Thomas C Wetter | |
| | Thomas Pollmächer | |
| | Andreas Schuld | |
| | Ekkehard D Albert | |
| | Mira Dalal | |
| P2860 | cites work | The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene | Q28142783 |
| | A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains | Q28145391 |
| | Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation | Q29615680 |
| | Obesity as a medical problem | Q29616305 |
| | Narcolepsy: a key role for hypocretins (orexins) | Q33730730 |
| | Orexins and orexin receptors: implication in feeding behavior | Q33788753 |
| | Current and potential drugs for treatment of obesity | Q33799836 |
| | Genetics of body-weight regulation | Q33892344 |
| | Reduced number of hypocretin neurons in human narcolepsy | Q33923479 |
| | The effects of leptin on REM sleep and slow wave delta in rats are reversed by food deprivation | Q38320875 |
| | Down regulation of the prepro-orexin gene expression in genetically obese mice | Q38327773 |
| | Reduced leptin levels in human narcolepsy | Q40739688 |
| | Genetic and familial aspects of narcolepsy | Q41713413 |
| | The disease burden associated with overweight and obesity | Q44817527 |
| | Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine | Q47236127 |
| | Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial | Q47254016 |
| | REM sleep disinhibition at sleep onset: a comparison between narcolepsy and depression | Q48610492 |
| | Increased prevalence of obesity in narcoleptic patients and relatives | Q48691377 |
| | Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity | Q48691942 |
| | Narcolepsy and obesity: remission of severe cataplexy with sibutramine | Q48706402 |
| | Circadian temperature and activity rhythms in unmedicated narcoleptic patients. | Q50934144 |
| | Increased body-mass index in patients with narcolepsy. | Q54565465 |
| | Hypocretin (orexin) deficiency in human narcolepsy. | Q55033530 |
| | Aprepro-orexingene polymorphism is associated with narcolepsy: Table 1 | Q60689234 |
| | Narcolepsy | Q68526268 |
| | Obstructive sleep apnea | Q70812476 |
| | Use of percentiles for the body mass index in anorexia nervosa: diagnostic, epidemiological, and therapeutic considerations | Q73349674 |
| | Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients | Q74096783 |
| P433 | issue | 4 | |
| P921 | main subject | narcolepsy | Q189561 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 335-339 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | Sleep Medicine | Q15762248 |
| P1476 | title | Increased body mass index (BMI) in male narcoleptic patients, but not in HLA-DR2-positive healthy male volunteers | |
| P478 | volume | 3 | |